NI
EDIT icon

Numeric Investors’s Editas Medicine EDIT Stock Holding History

Numeric Investors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$959K Sell
31,200
-239,000
-88% -$6.02M 0.01% 756
2017
Q3 		$6.49M Buy
+270,200
New +$5.14M 0.05% 352

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Numeric Investors's EDIT Position: Q4 2017 in Review

Numeric Investors reduced its Editas Medicine (EDIT) stake by 88% in Q4 2017, selling an estimated $6.02M and leaving 31,200 shares worth $959K. The position accounts for 0.01% of the portfolio, ranked #756.

Numeric Investors first reported a position in EDIT in Q3 2017 and has held it in 2 quarters since. The position peaked at $6.49M in Q3 2017. 151 funds tracked by Wall St. Rank hold EDIT as of Q4 2017.

  • Numeric Investors held 31,200 shares of Editas Medicine worth $959K as of Q4 2017.
  • Numeric Investors sold 239,000 Editas Medicine shares in Q4 2017, an estimated $6.02M.
  • Editas Medicine made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #756 holding.
  • Numeric Investors first reported a position in Editas Medicine in Q3 2017 and has held it in 2 quarters since.
  • Numeric Investors's Editas Medicine position peaked at $6.49M in Q3 2017.
  • 151 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.